Aspirus Regional Cancer Center

Cancer Clinical Trials

This is a current listing of active clinical trials at the Aspirus Regional Cancer Center. From this list you can select a specific cancer that you are interested in (for example, breast or colon cancer) and then review the clinical trials that are active at the Aspirus Regional Cancer Center for that specific disease.

Non-Small Cell Lung Cancer

Trial Name: Randomized Phase II Study of Suramin and Docetaxel Versus Docetaxel in Non-Small Cell Lung Cancer After Failure of First-Line Chemotherapy.

Protocol ID: CO11508

Eligibility:

Inclusion Criteria

  • Pathologically proven diagnosis of non-small cell lung cancer
  • Stable and treated CNS metastasis is allowed
  • Woman and men of child-bearing potential must use adequate birth control
  • Must meet required laboratory values

Exclusion Criteria

  • Severe hypersensitivity reaction to docetaxel

Women who are pregnant or breast-feeding

Enrollment: • Approximately 80 participants

Benefits:

 

No direct benefit is guaranteed to you from participating in this study.  Your participation in this research may benefit other people in the future by helping us learn more about lung cancer treatment.

Contact:

These clinical trial overviews are intended to provide a brief overview of the clinical trial. To help determine whether the trial is appropriate for you, the major eligibility criteria are listed above. To obtain more information on the eligibility and the treatment plan, please contact our Oncology Clinical Research Coordinator, Beth Knetter at 715-847-2353 or 1-800-283-2881, ext.72353.

Created: Jan 18, 2013

Updated: Feb 24, 2014

« Return to Trials